Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice

被引:0
作者
Rostyslav Bubnov
Lidiia Babenko
Liudmyla Lazarenko
Maryna Kryvtsova
Oleksandr Shcherbakov
Nadiya Zholobak
Olga Golubnitschaja
Mykola Spivak
机构
[1] National Academy of Sciences of Ukraine,Zabolotny Institute of Microbiology and Virology
[2] Clinical Hospital “Pheophania” of State Affairs Department,Radiological Clinic, UKB
[3] Excellence University of Bonn,Breast Cancer Research Centre, UKB
[4] Excellence University of Bonn,Centre for Integrated Oncology, Cologne
[5] Excellence University of Bonn,Bonn, UKB
[6] LCL ‘DIAPROF’,undefined
来源
EPMA Journal | 2019年 / 10卷
关键词
Predictive preventive personalized medicine; Nanoceria; Nanoparticles; Prebiotic; Probiotic; Obesity; Metabolic syndrome; Atherosclerosis; Animal model; Improved metabolism; In vivo; Microbiome; Gut microbiota; Lactobacillus; Bifidobacterium; Cholesterol; Phenotype;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:317 / 335
页数:18
相关论文
共 540 条
[1]  
Duarte AA(2018)Diabetes care in figures: current pitfalls and future scenario EPMA J 9 125-131
[2]  
Mohsin S(2016)Costigliola V. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016 EPMA J 7 23-1932
[3]  
Golubnitschaja O(2015)Probiotics and immunity: provisional role for personalized diets and disease prevention EPMA J 6 14-203
[4]  
Golubnitschaja O(2011)Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation Arterioscler Thromb Vasc Biol 31 1927-38
[5]  
Baban B(2005)Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Crit Pathw Cardiol 4 198-14
[6]  
Boniolo G(2016)Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian Population Int J Med Sci 13 25-97
[7]  
Wang W(2017)How do probiotics and prebiotics function at distant sites? Benefic Microbes 20 1-74
[8]  
Bubnov R(2018)Metabolic products of the intestinal microbiome and extremes of atherosclerosis Atherosclerosis. 273 91-575
[9]  
Kapalla M(2016)Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial Cell Metab 24 63-34
[10]  
Krapfenbauer K(2015)Probiotics for weight loss: a systematic review and meta-analysis Nutr Res 35 566-376